Investment Attraction
Invest in Manchester
Full Credential Description
Seda Group, a pioneering life sciences company specializing in pharmaceutical development and clinical manufacturing services, faced significant challenges in expanding its operational capacity to meet growing demand. The company sought a strategic location for its new manufacturing hub that would not only accommodate its expansion but also enhance its operational efficiency. After careful consideration, Seda Group chose Cheadle as the site for its new £8 million manufacturing facility.
The tailored solution involved establishing a state-of-the-art manufacturing hub designed to support Seda Group's innovative pharmaceutical development processes. This facility was strategically located to leverage Greater Manchester's robust life sciences ecosystem, which includes access to skilled labor, research institutions, and a network of suppliers and partners in the pharmaceutical sector.
As a result of this strategic move, Seda Group has positioned itself to significantly increase its production capabilities, thereby enhancing its ability to meet client demands and accelerate the development of new pharmaceutical products. The investment in the Cheadle facility is expected to yield substantial benefits, including improved operational efficiencies and the potential for increased revenue streams as the company scales its manufacturing operations to support a growing portfolio of clinical trials and product launches.